Principal Financial Group’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.42M Buy
191,776
+910
+0.5% +$21.3K ﹤0.01% 1649
2026
Q1
$3.64M Buy
190,866
+4,253
+2% +$94K ﹤0.01% 1712
2025
Q4
$4.51M Sell
186,613
-951
-0.5% -$24.9K ﹤0.01% 1651
2025
Q3
$4.78M Buy
187,564
+3,465
+2% +$82.2K ﹤0.01% 1602
2025
Q2
$3.97M Sell
184,099
-75,389
-29% -$1.7M ﹤0.01% 1650
2025
Q1
$5.93M Buy
259,488
+15,241
+6% +$401K ﹤0.01% 1508
2024
Q4
$6.34M Buy
244,247
+53,532
+28% +$1.33M ﹤0.01% 1512
2024
Q3
$4.78M Buy
190,715
+8,580
+5% +$203K ﹤0.01% 1587
2024
Q2
$3.9M Sell
182,135
-9,096
-5% -$177K ﹤0.01% 1614
2024
Q1
$3.55M Buy
191,231
+3,925
+2% +$68.6K ﹤0.01% 1675
2023
Q4
$3.04M Sell
187,306
-3,194
-2% -$40.7K ﹤0.01% 1702
2023
Q3
$2.63M Sell
190,500
-14,143
-7% -$223K ﹤0.01% 1714
2023
Q2
$4.52M Sell
204,643
-8,427
-4% -$177K ﹤0.01% 1567
2023
Q1
$4.63M Sell
213,070
-2,763
-1% -$62.1K ﹤0.01% 1551
2022
Q4
$3.93M Buy
215,833
+1,086
+0.5% +$22.4K ﹤0.01% 1607
2022
Q3
$4.89M Buy
214,747
+21,349
+11% +$457K ﹤0.01% 1496
2022
Q2
$2.67M Sell
193,398
-9,014
-4% -$132K ﹤0.01% 1742
2022
Q1
$4.6M Buy
202,412
+2,431
+1% +$64K ﹤0.01% 1688
2021
Q4
$7.45M Sell
199,981
-30,424
-13% -$1.31M ﹤0.01% 1532
2021
Q3
$9.75M Buy
230,405
+222,848
+2,949% +$10.7M 0.01% 1412
2021
Q2
$336K Buy
7,557
+447
+6% +$15.7K ﹤0.01% 2322
2021
Q1
$256K Buy
7,110
+501
+8% +$19.8K ﹤0.01% 2319
2020
Q4
$264K Buy
+6,609
New +$225K ﹤0.01% 2261

Other funds holding BLFS

Principal Financial Group's BLFS Position: Q2 2026 in Review

Principal Financial Group increased its BioLife Solutions (BLFS) stake by 0.48% in Q2 2026, buying an estimated $21.3K and bringing the position to 191,776 shares worth $5.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

Principal Financial Group first reported a position in BLFS in Q4 2020 and has held it in 23 quarters since. The position peaked at $9.75M in Q3 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Principal Financial Group held 191,776 shares of BioLife Solutions worth $5.42M as of Q2 2026.
  • Principal Financial Group bought 910 BioLife Solutions shares in Q2 2026, an estimated $21.3K.
  • BioLife Solutions made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1649 holding.
  • Principal Financial Group first reported a position in BioLife Solutions in Q4 2020 and has held it in 23 quarters since.
  • Principal Financial Group's BioLife Solutions position peaked at $9.75M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.